We are live on ! Find out more
RNF

RENTECH NITROGEN PARTNERS, L.P. INT
RNF

Delisted

RNF was delisted on the 31st of March, 2016.

35 hedge funds and large institutions have $77.6M invested in RENTECH NITROGEN PARTNERS, L.P. INT in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 12

4% more capital invested

Capital invested by funds: $74.3M → $77.6M (+$3.27M)

20% less funds holding

Funds holding: 4435 (-9)

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

62% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 13

84% less call options, than puts

Call options by funds: $1.6M | Put options by funds: $9.76M

Holders
35
Holders Change
-9
Holders Change %
-20.45%
% of All Funds
0.94%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.08%
New
5
Increased
15
Reduced
12
Closed
13
Calls
$1.6M
Puts
$9.76M
Net Calls
-$8.16M
Net Calls Change
-$11.8M
Name Holding Trade Value Shares
Change
Change in
Stake
BG
26
Bollard Group
Massachusetts
$211K
HCM
27
Hilton Capital Management
New York
$123K +$149K +10,000 New
Wells Fargo
28
Wells Fargo
California
$57K -$892 -60 -1%
US Bancorp
29
US Bancorp
Minnesota
$53K +$5.95K +400 +12%
Deutsche Bank
30
Deutsche Bank
Germany
$51K -$32.6K -2,195 -38%
PAM
31
Panagora Asset Management
Massachusetts
$43K +$45.1K +3,035 New
AIG
32
American International Group
New York
$38.6K -$17.8K -1,200 -31%
PCM
33
Prelude Capital Management
New York
$17K +$17.8K +1,200 New
Bank of Montreal
34
Bank of Montreal
Ontario, Canada
$10K +$4.31K +290 +73%
TRCT
35
Tower Research Capital (TRC)
New York
$1K -$24.9K -1,676 -95%
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$525 +$506K +34,023 +1,267%
SC
37
Sophrosyne Capital
New York
-$1.99M -131,900 Closed
HHAM
38
HITE Hedge Asset Management
Massachusetts
-$1.87M -125,722 Closed
HighTower Advisors
39
HighTower Advisors
Illinois
-$967K -64,236 Closed
CBOA
40
Commonwealth Bank of Australia
Australia
-$869K -57,675 Closed
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
-$228K -15,321 Closed
AGM
42
Alpine Global Management
New York
-$164K -10,900 Closed
CM
43
CoreCommodity Management
Connecticut
-$115K -7,631 Closed
Citadel Advisors
44
Citadel Advisors
Florida
-$87.6K -5,892 Closed
Creative Planning
45
Creative Planning
Kansas
-$49K -3,225 Closed
Parallax Volatility Advisers
46
Parallax Volatility Advisers
California
-$12K -818 Closed
AC
47
Alexandria Capital
Virginia
-$3K -230 Closed
BRWM
48
B. Riley Wealth Management
Tennessee
-$3K -200 Closed
PNC Financial Services Group
49
PNC Financial Services Group
Pennsylvania
-$2K -150 Closed

RNF Hedge Fund Activity: Q2 2015 in Review

35 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in RENTECH NITROGEN PARTNERS, L.P. INT (RNF) for Q2 2015, worth a combined $77.6M — up 4.4% from $74.3M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of RNF and 5 opened new positions — a net loss of 8 holders — while 12 trimmed existing stakes and 15 added.

The largest buyer was UBS Group, adding an estimated $9.5M. The largest seller was Sophrosyne Capital, exiting entirely with an estimated $1.99M sold.

  • 35 institutional investors held RENTECH NITROGEN PARTNERS, L.P. INT (RNF) as of Q2 2015, down from 44 in Q1 2015.
  • Funds reported $77.6M of RENTECH NITROGEN PARTNERS, L.P. INT stock for Q2 2015, up 4.4% quarter-over-quarter.
  • 5 funds opened new RENTECH NITROGEN PARTNERS, L.P. INT positions in Q2 2015 and 13 closed out, a net change of -8 holders.
  • The largest RENTECH NITROGEN PARTNERS, L.P. INT buyer in Q2 2015 was UBS Group, an estimated $9.5M added.
  • The largest RENTECH NITROGEN PARTNERS, L.P. INT seller in Q2 2015 was Sophrosyne Capital, an estimated $1.99M sold.

Based on aggregated 13F filings for Q2 2015.